The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
2007

Association of PTPN22 Polymorphism with Early Rheumatoid Arthritis

Sample size: 505 publication 10 minutes Evidence: high

Author Information

Author(s): Heidi Kokkonen, Martin Johansson, Lena Innala, Erik Jidell, Solbritt Rantapää-Dahlqvist

Primary Institution: Department of Rheumatology, University Hospital, Umeå, Sweden

Hypothesis

Is the PTPN22 1858C/T polymorphism associated with early rheumatoid arthritis in northern Sweden?

Conclusion

The PTPN22 1858C/T polymorphism is associated with early rheumatoid arthritis, particularly in seropositive cases, and is linked to an earlier onset of the disease.

Supporting Evidence

  • Carriage of the T variant of PTPN22 significantly increases the odds of developing RA.
  • The study included a large cohort of patients and matched controls.
  • The association was confined to seropositive rheumatoid arthritis cases.

Takeaway

This study found that a specific gene variant is linked to an increased risk of developing rheumatoid arthritis and that people with this variant tend to get the disease earlier.

Methodology

A case-control study was performed with 505 patients with early RA and 970 matched controls, analyzing the association of the PTPN22 polymorphism with disease markers.

Potential Biases

Potential selection bias in the cohort and reliance on self-reported smoking status.

Limitations

The study may not be generalizable beyond the northern Swedish population and the sample size for some analyses was small.

Participant Demographics

505 patients (342 females, 163 males) with early RA, mean age 54.5 years.

Statistical Information

P-Value

0.000001

Confidence Interval

1.36–2.11

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/ar2214

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication